Results 31 to 40 of about 112,946 (256)

Targeted microbubbles: a novel application for the treatment of kidney stones [PDF]

open access: yes, 2015
Kidney stone disease is endemic. Extracorporeal shockwave lithotripsy was the first major technological breakthrough where focused shockwaves were used to fragment stones in the kidney or ureter. The shockwaves induced the formation of cavitation bubbles,
Bailey, Michael   +8 more
core   +1 more source

Ex vivo renal perfusion and autotransplantation in treatment of calculous disease or abdominal aortic aneurysm. [PDF]

open access: yes, 1975
Two more indications are described for temporary ex vivo perfusion of kidneys with revascularization of these organs as autografts to orthotopic or heterotopic locations. One of the patients had staghorn calculi which were removed from a solitary kidney.
Belzer   +17 more
core   +1 more source

Kidney stone disease [PDF]

open access: yesJournal of Clinical Investigation, 2005
About 5% of American women and 12% of men will develop a kidney stone at some time in their life, and prevalence has been rising in both sexes. Approximately 80% of stones are composed of calcium oxalate (CaOx) and calcium phosphate (CaP); 10% of struvite (magnesium ammonium phosphate produced during infection with bacteria that possess the enzyme ...
Fredric L. Coe   +2 more
openaire   +3 more sources

Treatment of renal stones by extracorporeal shockwave lithotripsy - An update [PDF]

open access: yes, 2001
Aim: Despite the extensive experience with minimal invasive stone therapy, there are still different views on the ideal management of renal stones. Materials and Methods: Analysis of the literature includes more than 14,000 patients.
Chaussy, Christian   +3 more
core   +1 more source

Cost-effectiveness analysis of the management of distal ureteral stones in children [PDF]

open access: yes, 2019
Objective To determine the most cost-effective approach to the management of distal ureteral stones in children given the potential for recurrent renal colic during a trial of passage versus potential stent discomfort and complications of ureteroscopy.
Bennett, William E., Jr.   +6 more
core   +1 more source

Kidney stones among Iranian adults: Prevalence and socioeconomic inequality assessment in a cohort‐based cross‐sectional study

open access: yesHealth Science Reports, 2022
Background and Aims Kidney stone disease is a crystal concretion formed usually within the kidneys. The worldwide prevalence of kidney stones could be affected by numerous differences in socioeconomic, and environmental factors. The purpose of this study
Telma Zahirian Moghadam   +3 more
doaj   +1 more source

Oxalate as a potent promoter of kidney stone formation

open access: yesFrontiers in Medicine, 2023
Kidney stones are among the most prevalent urological diseases, with a high incidence and recurrence rate. Treating kidney stones has been greatly improved by the development of various minimally invasive techniques.
Tao Chen   +19 more
doaj   +1 more source

Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin) : study protocol for a randomized controlled trial [PDF]

open access: yes, 2014
Peer reviewedPublisher ...
Anson, Ken   +12 more
core   +2 more sources

Trends of intervention for paediatric stone disease over the last two decades (2000–2015): A systematic review of literature [PDF]

open access: yes, 2017
Objective: To ascertain the publication trends of interventions for paediatric kidney stone disease (KSD) we conducted a systematic review of literature over the last 16 years.
Aboumarzouk, Omar   +6 more
core   +2 more sources

Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer. [PDF]

open access: yes, 2018
BACKGROUND: Intravenous ascorbic acid (IV AA) has been used extensively in cancer patients throughout the United States. Currently, there are limited data on the safety and clinical effects of IV AA.
Bazzan, Anthony J.   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy